| scholarly article | Q13442814 |
| P2093 | author name string | Seabrook GR | |
| Rothwell LA | |||
| Bowery B | |||
| P2860 | cites work | Two cell types in rat substantia nigra zona compacta distinguished by membrane properties and the actions of dopamine and opioids | Q69581473 |
| Neurotransmitter regulation of dopamine neurons in the ventral tegmental area | Q72215317 | ||
| Behavioural effects of the putative D-3 dopamine receptor agonist 7-OH-DPAT in relation to other "D-2-like" agonists | Q72806301 | ||
| Dopamine D4 receptors elevated in schizophrenia | Q24318936 | ||
| Functional expression of human D3 dopamine receptors in differentiated neuroblastoma x glioma NG108-15 cells | Q24319600 | ||
| Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine | Q24319813 | ||
| Expression and pharmacological characterization of the human D3 dopamine receptor | Q24337093 | ||
| Identification, characterization, and localization of the dopamine D3 receptor in rat brain using 7-[3H]hydroxy-N,N-di-n-propyl-2-aminotetralin | Q24564132 | ||
| Electrophysiological characterization of potent agonists and antagonists at pre- and postsynaptic GABAB receptors on neurones in rat brain slices | Q24673400 | ||
| Actions of cocaine on rat dopaminergic neurones in vitro | Q24673575 | ||
| Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics | Q28258681 | ||
| Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist | Q28282022 | ||
| Depression of high-threshold calcium currents by activation of human D2 (short) dopamine receptors expressed in differentiated NG108-15 cells | Q28369308 | ||
| Cloning and expression of a rat D2 dopamine receptor cDNA | Q28567326 | ||
| Activation of heterologously expressed D3 dopamine receptors: comparison with D2 dopamine receptors | Q28579418 | ||
| Some quantitative uses of drug antagonists | Q29616831 | ||
| Differential effects of dopamine agonists upon stimulated limbic and striatal dopamine release: in vivo voltammetric data | Q31043351 | ||
| Dopaminergic mechanisms in the pathogenesis of schizophrenia | Q35252902 | ||
| Developments in the drug treatment of schizophrenia | Q35254162 | ||
| The electrophysiological actions of dopamine and dopaminergic drugs on neurons of the substantia nigra pars compacta and ventral tegmental area | Q35264000 | ||
| Dopamine receptor sequences. Therapeutic levels of neuroleptics occupy D2 receptors, clozapine occupies D4 | Q35275118 | ||
| Clozapine: a hypothesised mechanism for its unique clinical profile | Q35454678 | ||
| Clinical efficacy of clozapine in treatment-refractory schizophrenia: an overview | Q35454754 | ||
| Multiple receptors for dopamine | Q37876912 | ||
| Drugs and receptors. An overview of the current state of knowledge | Q38037989 | ||
| Acute and chronic haloperidol treatment: Comparison of effects on nigral dopaminergic cell activity | Q39223366 | ||
| A proposed new nomenclature for 5-HT receptors. | Q40846227 | ||
| The actions of antipsychotic drugs on dopamine receptors in the rat substantia nigra | Q41746183 | ||
| Selectivity of (+)-4-propyl-9-hydroxynaphthoxazine [(+)-PHNO] for dopamine receptors in vitro and in vivo | Q42204898 | ||
| A mechanism underlying dopamine D1 and D2 receptor-mediated inhibition of dopaminergic neurones in the ventral tegmental area in vitro | Q42237153 | ||
| Sertindole, a new neuroleptic with extreme selectivity on A10 versus A9 dopamine neurones in the rat. | Q42475000 | ||
| Dopamine acts on D2 receptors to increase potassium conductance in neurones of the rat substantia nigra zona compacta | Q45053894 | ||
| Differential effects after repeated treatment with haloperidol, clozapine, thioridazine and tefludazine on SNC and VTA dopamine neurones in rats | Q48161601 | ||
| Interaction of antipsychotic drugs with neurotransmitter receptor sites in vitro and in vivo in relation to pharmacological and clinical effects: role of 5HT2 receptors | Q48392880 | ||
| Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA. | Q48623758 | ||
| Pharmacologic profile of a novel potent direct-acting dopamine agonist, (+)-4-propyl-9-hydroxynaphthoxazine [(+)-PHNO]. | Q48629019 | ||
| Sensitivity of compacta neurones in the rat substantia nigra slice to dopamine agonists. | Q48703590 | ||
| Differential Effects of Classical and Atypical Antipsychotic Drugs on A9 and A10 Dopamine Neurons | Q48738943 | ||
| Irreversible receptor inactivation reveals differences in dopamine receptor reserve between A9 and A10 dopamine systems: an electrophysiological analysis. | Q48858077 | ||
| Ritanserin, a 5-HT2 receptor antagonist, activates midbrain dopamine neurons by blocking serotonergic inhibition. | Q48933326 | ||
| On the potassium conductance increase activated by GABAB and dopamine D2 receptors in rat substantia nigra neurones. | Q52426640 | ||
| Sensitivity of neuronal dopamine response in the substantia nigra and ventral tegmentum to clozapine, metoclopramide and SCH 23390 | Q68156537 | ||
| Differential effects of acute clozapine and haloperidol on the activity of ventral tegmental (A10) and nigrostriatal (A9) dopamine neurons | Q69118988 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | substantia nigra | Q753278 |
| P304 | page(s) | 873-880 | |
| P577 | publication date | 1994-07-01 | |
| P1433 | published in | British Journal of Pharmacology | Q919631 |
| P1476 | title | Comparison between the pharmacology of dopamine receptors mediating the inhibition of cell firing in rat brain slices through the substantia nigra pars compacta and ventral tegmental area | |
| P478 | volume | 112 |
| Q40972315 | Activation of human D3 dopamine receptor inhibits P/Q-type calcium channels and secretory activity in AtT-20 cells. |
| Q24674289 | Antagonism of the effects of (+)-PD 128907 on midbrain dopamine neurones in rat brain slices by a selective D2 receptor antagonist L-741,626. |
| Q34212329 | BP 897, a selective dopamine D3 receptor ligand with therapeutic potential for the treatment of cocaine-addiction. |
| Q36144677 | Characterization of 4-(2-hydroxyphenyl)-1-[2'-[N-(2''-pyridinyl)-p-fluorobenzamido]ethyl]piperazine (p-DMPPF) as a new potent 5-HT1A antagonist |
| Q33894877 | Dopamine 2 Receptor Activation Entrains Circadian Clocks in Mouse Retinal Pigment Epithelium |
| Q36512027 | Dopamine activates noradrenergic receptors in the preoptic area. |
| Q44296068 | Electrophysiological and pharmacological characteristics of nigral dopaminergic neurons in the conscious, head-restrained rat. |
| Q41560128 | Electrophysiological pharmacology of the autoreceptor-mediated responses of dopaminergic cells to antiparkinsonian drugs. |
| Q35727823 | Emotional Eating Phenotype is Associated with Central Dopamine D2 Receptor Binding Independent of Body Mass Index |
| Q50741418 | Human D2 and D4 dopamine receptors couple through betagamma G-protein subunits to inwardly rectifying K+ channels (GIRK1) in a Xenopus oocyte expression system: selective antagonism by L-741,626 and L-745,870 respectively. |
| Q43621344 | In vitro modulation of the firing rate of dopamine neurons in the rat substantia nigra pars compacta and the ventral tegmental area by antipsychotic drugs |
| Q41232968 | Mechanisms of action of atypical antipsychotic drugs: a critical analysis |
| Q91781384 | Modulation of Functional Connectivity Between Dopamine Neurons of the Rat Ventral Tegmental Area in vitro |
| Q48757927 | Monoamine oxidase inhibition causes a long-term prolongation of the dopamine-induced responses in rat midbrain dopaminergic cells. |
| Q49068948 | Olanzapine, a novel atypical antipsychotic, reverses d-amphetamine-induced inhibition of midbrain dopamine cells. |
| Q37656934 | Prefrontal Dopaminergic Mechanisms of Extinction in Adolescence Compared to Adulthood in Rats. |
| Q44784005 | Repeated exposure to MDMA and amphetamine: sensitization, cross-sensitization, and response to dopamine D₁- and D₂-like agonists |
| Q34432978 | Schizophrenia and L-745,870, a novel dopamine D4 receptor antagonist |
| Q48569095 | Selective effects on prefrontal cortex serotonin by dopamine D3 receptor agonism: interaction with low-dose haloperidol. |
| Q33862978 | The connections of the dopaminergic system with the striatum in rats and primates: an analysis with respect to the functional and compartmental organization of the striatum |
| Q43690241 | The dopamine D3 receptor partial agonist, BP 897, is an antagonist at human dopamine D3 receptors and at rat somatodendritic dopamine D3 receptors |
| Q46699862 | The role of central 5-HT receptors in the bronchoconstriction evoked by inhaled capsaicin in anaesthetised guinea-pigs |
| Q35751683 | Tyramine excites rat subthalamic neurons in vitro by a dopamine-dependent mechanism |
Search more.